Dr. Andrew Frank: key facts
- Kind of voice
- Academic
- Role
- cognitive neurologist and researcher at Bruyère Health Memory Clinic at Bruyère Health in Ottawa
- Quoted on
- Dementia
- Tracked press citations
- 3
- Most recently quoted
- 30 Sept 2026
“That is part of what will make treatment with the drug complicated, said Dr. Andrew Frank, a cognitive neurologist and researcher at Bruyère Health Memory Clinic at Bruyère Health in Ottawa. Bruyère Health hopes to be among the first locations in the region to make the treatment available to those who qualify, he said.”
What Dr. Andrew Frank has said
“Possible side-effects of lecanemab include brain swelling or bleeding, although in most cases they are visible on MRI scans but don't cause any symptoms.”
cognitive neurologist and medical director of the Bruyere Memory Program in Ottawa · Dementia · 30 Sept 2026 · Drug to slow early-stage Alzheimer’s disease approved by Health Canada ↗
“This means there will be less access for patients”
cognitive neurologist and investigator at the Bruyère Memory Program in Ottawa · Dementia · 30 Sept 2026 · Canada's Drug Agency recommends new Alzheimer's drug not be publicly funded ↗
Where Dr. Andrew Frank has been quoted
- Approval of new Alzheimer's drug in Canada called historicottawacitizen.com · 30 Sept 2026
- Drug to slow early-stage Alzheimer’s disease approved by Health Canadaici.radio-canada.ca · 30 Sept 2026
- Canada's Drug Agency recommends new Alzheimer's drug not be publicly fundedottawacitizen.com · 30 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.